Emapalumab Effective in Rheumatologic Disease–Associated HLH
TOPLINE:Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic ...